January 18, 2018

Pillet S et al. NPJ Vaccines 2018;23(3):3.

Humoral and Cell-Mediated Immune Responses to H5N1 Plant-Made Virus-Like Particle Vaccine Are Differentially Impacted by Alum and GLA-SE Adjuvants in a Phase 2 Clinical Trial

Download publication

You might also be interested by

Brochures

High Performance Technologies for Cytokine Measurement

November 8, 2021

Immune Monitoring

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info

Brochures

Oncology & Immuno-Oncology Expertise

November 5, 2021

Histopathology

More info

Infographics

Advance Your Cell Therapy with Cross-Platform Capabilities

November 5, 2021

Histopathology

More info